ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 35 filers reported holding ADICET BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,315 | -63.4% | 7,529 | -35.0% | 0.00% | – |
| Q2 2023 | $28,149 | -9.5% | 11,584 | +114.6% | 0.00% | – |
| Q1 2023 | $31,092 | +139.2% | 5,398 | +484.8% | 0.00% | – |
| Q3 2022 | $13,000 | +225.0% | 923 | +215.0% | 0.00% | – |
| Q2 2022 | $4,000 | -87.9% | 293 | -82.0% | 0.00% | – |
| Q1 2022 | $33,000 | -78.3% | 1,628 | -81.3% | 0.00% | – |
| Q4 2021 | $152,000 | +52.0% | 8,686 | -32.1% | 0.00% | – |
| Q3 2021 | $100,000 | – | 12,797 | +1279600.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2020 | $130,000 | – | 9,289 | +928800.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |